4
Changes in Ownership
RESMED INC Filed Acc 0001127602-23-027688
Chief Executive Officer sold 5,678 shares at $152.04 ($863,281)
- Chief Executive Officer acquired 5,678 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,678 | $57.76 | $327,961 | 446,664 | D |
| 2023-11-15 | Sale : show line 2 in the form 10b5-1 | −5,678 | $152.04 | $863,281 | 440,986 | D |
| Open-market sales · 5,678 sh · avg $152.04 · $863,281 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-15 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −5,678 | 3,462 | D |
Loading xslF345X05/form4.xml…